DTL
IBRX icon

Dynamic Technology Lab’s ImmunityBio IBRX Stock Holding History

Dynamic Technology Lab’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,435
Closed -$35K – 1174
2023
Q1 		$35K Buy
+19,435
New +$60.4K ﹤0.01% 1010
2021
Q2 		– Sell
-10,956
Closed -$260K – 1303
2021
Q1 		$260K Buy
+10,956
New +$284K 0.03% 843
2017
Q2 		– Sell
-32,939
Closed -$117K – 1159
2017
Q1 		$117K Buy
32,939
+11,465
+53% +$56.6K 0.03% 889
2016
Q4 		$123K Buy
21,474
+10,551
+97% +$70.4K 0.03% 790
2016
Q3 		$85K Buy
+10,923
New +$81.6K 0.02% 823

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return

Dynamic Technology Lab's IBRX Position: Q2 2023 in Review

Dynamic Technology Lab sold out of ImmunityBio (IBRX) in Q2 2023, closing a stake of 19,435 shares — an estimated $35K sold.

Dynamic Technology Lab first reported a position in IBRX in Q3 2016 and held it in 5 quarters. The position peaked at $260K in Q1 2021. 117 funds tracked by Wall St. Rank hold IBRX as of Q2 2023.

  • Dynamic Technology Lab reported no remaining ImmunityBio position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 19,435 ImmunityBio shares in Q2 2023, an estimated $35K.
  • Dynamic Technology Lab first reported a position in ImmunityBio in Q3 2016 and held it in 5 quarters.
  • Dynamic Technology Lab's ImmunityBio position peaked at $260K in Q1 2021.
  • 117 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.